|
HY-125837A-10mg
|
MedChemexpress LLC
|
MS31 (trihydrochloride)
|
|
Cancer-programmed cell death
|
|
|
HY-125837A-100mg
|
MedChemexpress LLC
|
MS31 (trihydrochloride)
|
|
Cancer-programmed cell death
|
|
|
HY-125837A-5mg
|
MedChemexpress LLC
|
MS31 (trihydrochloride)
|
|
Cancer-programmed cell death
|
|
|
HY-125837A-50mg
|
MedChemexpress LLC
|
MS31 (trihydrochloride)
|
|
Cancer-programmed cell death
|
|
|
HY-125837A-1mL
|
MedChemexpress LLC
|
MS31 (trihydrochloride) [CAS ] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-125837-10mg
|
MedChemexpress LLC
|
MS31 [CAS 2366264-12-0]
|
|
Cancer-programmed cell death
|
|
|
HY-125837-100mg
|
MedChemexpress LLC
|
MS31 [CAS 2366264-12-0]
|
|
Cancer-programmed cell death
|
|
|
HY-125837-5mg
|
MedChemexpress LLC
|
MS31 [CAS 2366264-12-0]
|
|
Cancer-programmed cell death
|
|
|
HY-125837-50mg
|
MedChemexpress LLC
|
MS31 [CAS 2366264-12-0]
|
|
Cancer-programmed cell death
|
|
|
HY-P0280-1mg
|
MedChemexpress LLC
|
Mu C5AC motif peptide [CAS 244049-41-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0280-10mg
|
MedChemexpress LLC
|
Mu C5AC motif peptide [CAS 244049-41-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0280-5mg
|
MedChemexpress LLC
|
Mu C5AC motif peptide [CAS 244049-41-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1048-1mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1048-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1048-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2464-10mg
|
MedChemexpress LLC
|
Myosin H Chain Fragment, mouse
|
|
COVID-19-immunoregulation
|
|
|
HY-P2464-25mg
|
MedChemexpress LLC
|
Myosin H Chain Fragment, mouse
|
|
COVID-19-immunoregulation
|
|
|
HY-P2464-5mg
|
MedChemexpress LLC
|
Myosin H Chain Fragment, mouse
|
|
COVID-19-immunoregulation
|
|
|
HY-103693-10mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-100mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-25mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-5mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-50mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-1mL
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-P1601-1mg
|
MedChemexpress LLC
|
Neuropeptide Y(29-64) [CAS 303052-45-1]
|
|
Metabolism-protein/nucleotide metabolism
|
|
